

Benjamin S, Vi L, Chatterjee D, et al. Maternal autoantibodies to the sodium potassium pump α1 subunit AT1A1 and fetal autoimmune congenital heart block: a case-control study. Lancet Rheumatology 2025; 7: e554–64—In this Article, the last sentence of the Summary Findings should read “Anti-AT1A1 autoantibodies were absent in all unaffected pregnancies of women with no history of fetal heart block (autoimmune congenital heart block-naive, 54 [100%] of 54) and in 61 (94%) of 65 of unaffected pregnancies”.
Rheumatology
|31st Dec, 2025
|Journal of the American Medical Association
Rheumatology
|15th Jan, 2026
|The Lancet
Rheumatology
|15th Jan, 2026
|The Lancet
Rheumatology
|15th Jan, 2026
|The Lancet
Rheumatology
|15th Jan, 2026
|The Lancet
Rheumatology
|15th Jan, 2026
|The Lancet
Rheumatology
|15th Jan, 2026
|The Lancet